Myriad Genetics traded at $18.98 this Wednesday July 6th, increasing $0.14 or 0.74 percent since the previous trading session. Looking back, over the last four weeks, Myriad Genetics gained 1.44 percent. Over the last 12 months, its price fell by 40.78 percent. Looking ahead, we forecast Myriad Genetics to be priced at 18.13 by the end of this quarter and at 16.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
18.98
Daily Change
0.74%
Yearly
-40.78%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 121.47 0.91 0.75% -18.74%
Accelerate Diagnostics 1.20 0.19 18.81% -83.65%
Becton, Dickinson and Co. 247.63 -0.30 -0.12% -1.73%
Bio-Rad Laboratories 509.83 3.83 0.76% -24.29%
Biocept 0.99 0.04 4.27% -75.25%
Bruker 65.14 0.15 0.22% -17.77%
Quest Diagnostics 136.10 2.52 1.89% 1.09%
Danaher 259.59 4.08 1.60% -6.81%
Exact Sciences 43.42 -0.98 -2.21% -63.12%
Standard Biotools Inc 1.68 -0.06 -3.45% -71.53%
Hologic 70.74 0.55 0.78% 1.57%
Illumina 195.71 2.69 1.39% -58.66%
J&J 178.39 0.25 0.14% 5.30%
Mettler Toledo International 1,172.13 -3.35 -0.28% -18.37%
Myriad Genetics 18.98 0.14 0.74% -40.78%
NanoString Technologies 14.34 0.24 1.70% -76.94%
OraSure Technologies 2.77 -0.01 -0.36% -72.76%
Pacific Biosciences Of California 5.14 -0.06 -1.15% -83.99%
PerkinElmer 146.19 1.63 1.13% -5.71%
Quidel 105.87 5.46 5.44% -11.97%
Repligen 169.89 2.21 1.32% -17.71%
Thermo Fisher Scientific 554.70 9.63 1.77% 6.12%
Veracyte 23.93 0.52 2.22% -37.36%
Waters 342.26 2.60 0.77% -6.33%

Indexes Price Day Year
USND 11405 82.67 0.73% -22.23%

Myriad Genetics
Myriad Genetics, Inc. (Myriad) is a genetic testing and precision medicine company. Myriad is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. It operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can progress patient care. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. The Company's products include myRisk, BRACAnalysis, BRACAnalysis CDx myChoice CDx, Prolaris, EndoPredict, Foresight and Prequel.